Literature DB >> 18723334

HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.

Paola Rogliani1, Marco Mura, Paolo Mattia, Amedeo Ferlosio, Gianfranco Farinelli, Salvatore Mariotta, Paolo Graziano, Gabriella Pezzuto, Alberto Ricci, Cesare Saltini, Augusto Orlandi.   

Abstract

Idiopathic pulmonary fibrosis has been associated with emphysema in cigarette smokers as a new clinical entity: combined pulmonary fibrosis and emphysema (CPFE). In order to compare histomorphometrical, roentgenological and immunohistochemical aspects of usual interstitial pneumonia (UIP) with and without associated pulmonary emphysema, 17 patients with biopsy-proven UIP were evaluated. Morphometrical evaluation of lung parenchyma destruction was used to divide patients in two subgroups: emphysema/UIP (n=9) and UIP alone (n=8); four patients with biopsy-proven emphysema without fibrosis were also evaluated. At HRTC scan, emphysematous lesions were prevalent in the upper fields of both emphysema/UIP and emphysema groups and the distribution of fibrotic lesions was similar in emphysema/UIP compared to UIP alone. The semiquantitative histopathological fibrotic score was also similar in emphysema/UIP and UIP alone. In addition, the expression of tumor necrosis factor (TNF)-alpha, matrix metalloproteinase (MMP)-2, MMP-9, MMP-7 and membrane type 1-metalloproteinase (MT1-MMP) by fibroblasts of myofibroblastic foci was similar in emphysema/UIP and UIP alone patients. In contrast, fibroblasts in areas of parenchymal destruction of emphysema/UIP expressed MMP-2, MMP-9, MMP-7 and MT1-MMP at variable but significantly higher levels when compared to emphysema subjects, in the presence of similar levels of TIMP-1, TIMP-2 and TNF-alpha. Fibrotic and emphysematous lesions in emphysema/UIP patients appear to follow the roentgenological and histopathological patterns expected for either UIP or emphysema. Interstitial fibroblast activation is more pronounced in the areas of lung destruction in emphysema/UIP compared to those with emphysema alone, as for exaggerated tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723334     DOI: 10.1016/j.rmed.2008.07.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

Review 1.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

2.  Combined Pulmonary Fibrosis and Emphysema and Digital Clubbing.

Authors:  Taha F Rasul; Daniel R Bergholz; Randal Rovinski; Sana Gulraiz; Ernesto Fonts
Journal:  Cureus       Date:  2022-04-18

3.  Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema.

Authors:  Fushi Dong; Yimei Zhang; Fangzhou Chi; Qi Song; Lijuan Zhang; Yupeng Wang; Chunli Che
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 4.  Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings.

Authors:  Tae Iwasawa; Tamiko Takemura; Takashi Ogura
Journal:  Jpn J Radiol       Date:  2017-12-15       Impact factor: 2.374

5.  Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases.

Authors:  Suzana Pinheiro Pimenta; Renata Barbosa da Rocha; Bruno Guedes Baldi; Alexandre de Melo Kawassaki; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease.

Authors:  Karina Portillo; Josep Morera
Journal:  Pulm Med       Date:  2012-02-09

7.  Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema).

Authors:  Fumikazu Sakai; Junya Tominaga; Akiko Kaga; Yutaka Usui; Minoru Kanazawa; Takashi Ogura; Noriyo Yanagawa; Tamiko Takemura
Journal:  Pulm Med       Date:  2012-02-09

Review 8.  Combined pulmonary fibrosis and emphysema: an increasingly recognized condition.

Authors:  Olívia Meira Dias; Bruno Guedes Baldi; André Nathan Costa; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

9.  A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema.

Authors:  Tomoo Kishaba; Yousuke Shimaoka; Hajime Fukuyama; Kyoko Yoshida; Maki Tanaka; Shin Yamashiro; Hitoshi Tamaki
Journal:  BMJ Open       Date:  2012-05-15       Impact factor: 2.692

10.  Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.

Authors:  Vincent Cottin
Journal:  BMC Res Notes       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.